Premium
[P1–461]: CSF Aβ1–42 AS THE PATHOLOGICAL AD BIOMARKER IN TYPE 2 DIABETES MELLITUS PATIENTS
Author(s) -
Li Wei,
Risacher Shan L.,
Gao Sujuan,
Saykin Andrew J.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.477
Subject(s) - pathological , biomarker , type 2 diabetes mellitus , medicine , cerebrospinal fluid , diabetes mellitus , alzheimer's disease neuroimaging initiative , disease , amyloid (mycology) , type 2 diabetes , gastroenterology , alzheimer's disease , endocrinology , oncology , pathology , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom